Cargando…

Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice

BACKGROUND AND AIMS: Cholestatic liver injury (CLI), which is associated with inflammatory reactions and oxidative stress, is a serious risk factor for postoperative complications. Complement system is involved in a wide range of liver disorders, including cholestasis. The present study assessed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zhenya, Chen, Junze, Zeng, Yonglian, Wang, Zefeng, Yao, Mei, Tomlinson, Stephen, Chen, Bin, Yuan, Guandou, He, Songqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777082/
https://www.ncbi.nlm.nih.gov/pubmed/35069557
http://dx.doi.org/10.3389/fimmu.2021.785287
_version_ 1784636984988270592
author Guo, Zhenya
Chen, Junze
Zeng, Yonglian
Wang, Zefeng
Yao, Mei
Tomlinson, Stephen
Chen, Bin
Yuan, Guandou
He, Songqing
author_facet Guo, Zhenya
Chen, Junze
Zeng, Yonglian
Wang, Zefeng
Yao, Mei
Tomlinson, Stephen
Chen, Bin
Yuan, Guandou
He, Songqing
author_sort Guo, Zhenya
collection PubMed
description BACKGROUND AND AIMS: Cholestatic liver injury (CLI), which is associated with inflammatory reactions and oxidative stress, is a serious risk factor for postoperative complications. Complement system is involved in a wide range of liver disorders, including cholestasis. The present study assessed the role of complement in CLI and the therapeutic effect of the site-targeted complement inhibitor CR2-Crry in CLI. METHODS: Wild-type and complement gene deficient mice underwent common bile duct ligation (BDL) to induce CLI or a sham operation, followed by treatment with CR2-Crry or GdCl3. The roles of complement in CLI and the potential therapeutic effects of CR2-Crry were investigated by biochemical analysis, flow cytometry, immunohistochemistry, ELISA, and quantitative RT-PCR. RESULTS: C3 deficiency and CR2-Crry significantly reduced liver injuries in mice with CLI, and also markedly decreasing the numbers of neutrophils and macrophages in the liver. C3 deficiency and CR2-Crry also significantly reduced neutrophil expression of Mac-1 and liver expression of VCAM-1. More importantly, C3 deficiency and CR2-Crry significantly inhibited M1 macrophage polarization in these mice. Intravenous injection of GdCl3 inhibited macrophage infiltration and activation in the liver. However, the liver injury increased significantly. BDL significantly increased the level of lipopolysaccharide (LPS) in portal blood, but not in peripheral blood. GdCl3 significantly increased LPS in peripheral blood, suggesting that macrophages clear portal blood LPS. Oral administration of ampicillin to in GdCl3 treated mice reduced LPS levels in portal blood and alleviated liver damage. In contrast, intraperitoneal injection LPS increased portal blood LPS and reversed the protective effect of ampicillin. Interestingly, C3 deficiency did not affect the clearance of LPS. CONCLUSIONS: Complement is involved in CLI, perhaps mediating the infiltration and activation of neutrophils and macrophage M1 polarization in the liver. C3 deficiency and CR2-Crry significantly alleviated CLI. Inhibition of complement could preserve the protective function of macrophages in clearing LPS, suggesting that complement inhibition could be useful in treating CLI.
format Online
Article
Text
id pubmed-8777082
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87770822022-01-22 Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice Guo, Zhenya Chen, Junze Zeng, Yonglian Wang, Zefeng Yao, Mei Tomlinson, Stephen Chen, Bin Yuan, Guandou He, Songqing Front Immunol Immunology BACKGROUND AND AIMS: Cholestatic liver injury (CLI), which is associated with inflammatory reactions and oxidative stress, is a serious risk factor for postoperative complications. Complement system is involved in a wide range of liver disorders, including cholestasis. The present study assessed the role of complement in CLI and the therapeutic effect of the site-targeted complement inhibitor CR2-Crry in CLI. METHODS: Wild-type and complement gene deficient mice underwent common bile duct ligation (BDL) to induce CLI or a sham operation, followed by treatment with CR2-Crry or GdCl3. The roles of complement in CLI and the potential therapeutic effects of CR2-Crry were investigated by biochemical analysis, flow cytometry, immunohistochemistry, ELISA, and quantitative RT-PCR. RESULTS: C3 deficiency and CR2-Crry significantly reduced liver injuries in mice with CLI, and also markedly decreasing the numbers of neutrophils and macrophages in the liver. C3 deficiency and CR2-Crry also significantly reduced neutrophil expression of Mac-1 and liver expression of VCAM-1. More importantly, C3 deficiency and CR2-Crry significantly inhibited M1 macrophage polarization in these mice. Intravenous injection of GdCl3 inhibited macrophage infiltration and activation in the liver. However, the liver injury increased significantly. BDL significantly increased the level of lipopolysaccharide (LPS) in portal blood, but not in peripheral blood. GdCl3 significantly increased LPS in peripheral blood, suggesting that macrophages clear portal blood LPS. Oral administration of ampicillin to in GdCl3 treated mice reduced LPS levels in portal blood and alleviated liver damage. In contrast, intraperitoneal injection LPS increased portal blood LPS and reversed the protective effect of ampicillin. Interestingly, C3 deficiency did not affect the clearance of LPS. CONCLUSIONS: Complement is involved in CLI, perhaps mediating the infiltration and activation of neutrophils and macrophage M1 polarization in the liver. C3 deficiency and CR2-Crry significantly alleviated CLI. Inhibition of complement could preserve the protective function of macrophages in clearing LPS, suggesting that complement inhibition could be useful in treating CLI. Frontiers Media S.A. 2022-01-07 /pmc/articles/PMC8777082/ /pubmed/35069557 http://dx.doi.org/10.3389/fimmu.2021.785287 Text en Copyright © 2022 Guo, Chen, Zeng, Wang, Yao, Tomlinson, Chen, Yuan and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Guo, Zhenya
Chen, Junze
Zeng, Yonglian
Wang, Zefeng
Yao, Mei
Tomlinson, Stephen
Chen, Bin
Yuan, Guandou
He, Songqing
Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
title Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
title_full Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
title_fullStr Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
title_full_unstemmed Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
title_short Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
title_sort complement inhibition alleviates cholestatic liver injury through mediating macrophage infiltration and function in mice
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777082/
https://www.ncbi.nlm.nih.gov/pubmed/35069557
http://dx.doi.org/10.3389/fimmu.2021.785287
work_keys_str_mv AT guozhenya complementinhibitionalleviatescholestaticliverinjurythroughmediatingmacrophageinfiltrationandfunctioninmice
AT chenjunze complementinhibitionalleviatescholestaticliverinjurythroughmediatingmacrophageinfiltrationandfunctioninmice
AT zengyonglian complementinhibitionalleviatescholestaticliverinjurythroughmediatingmacrophageinfiltrationandfunctioninmice
AT wangzefeng complementinhibitionalleviatescholestaticliverinjurythroughmediatingmacrophageinfiltrationandfunctioninmice
AT yaomei complementinhibitionalleviatescholestaticliverinjurythroughmediatingmacrophageinfiltrationandfunctioninmice
AT tomlinsonstephen complementinhibitionalleviatescholestaticliverinjurythroughmediatingmacrophageinfiltrationandfunctioninmice
AT chenbin complementinhibitionalleviatescholestaticliverinjurythroughmediatingmacrophageinfiltrationandfunctioninmice
AT yuanguandou complementinhibitionalleviatescholestaticliverinjurythroughmediatingmacrophageinfiltrationandfunctioninmice
AT hesongqing complementinhibitionalleviatescholestaticliverinjurythroughmediatingmacrophageinfiltrationandfunctioninmice